{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T13:16:39Z","timestamp":1782738999008,"version":"3.54.5"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,10,13]],"date-time":"2022-10-13T00:00:00Z","timestamp":1665619200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,10,13]],"date-time":"2022-10-13T00:00:00Z","timestamp":1665619200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Decreased pancreatic volume, increased pancreatic fat mass, and serrated pancreatic margins are characteristic morphological changes of the pancreas in subjects with type 2 diabetes mellitus. This retrospective study aimed to clarify the clinical significance of pancreatic morphological changes in subjects with type 2 diabetes mellitus who underwent abdominal magnetic resonance imaging. The mean age and HbA1c value were 59.1\u2009\u00b1\u200916.3\u00a0years old and 8.9\u2009\u00b1\u20092.3%, respectively. Pancreatic body mass corrected for body surface area (BSA) in subjects with diabetes mellitus was lower compared to those in normal glucose tolerance (49.4\u2009\u00b1\u200915.3 cm<jats:sup>3<\/jats:sup> vs. 60.9\u2009\u00b1\u20097.8 cm<jats:sup>3<\/jats:sup>), although it did not reach a statistic significance. There was a negative correlation between BSA-corrected pancreatic volume and age, duration of diabetes, glycoalbumin, mean and max IMT, and there was a positive correlation between BSA-corrected pancreatic volume and HOMA2-\u03b2. Serration of the pancreatic limbus was more often observed in subjects with diabetes mellitus compared to those in normal glucose tolerance (74.1% vs. 14.3%). Subjects with serrated changes were older and had higher HbA1c, and visceral fat area was significantly larger in subjects with serrated changes. BSA-corrected pancreatic volume in subjects with serrated changes was significantly smaller, and mean IMT was significantly thicker in subjects with serrulation. Furthermore, advanced diabetic retinopathy and diabetic nephropathy were more often observed in subjects with serrated changes. Taken together, decreased BSA-corrected pancreatic volume and serrated changes were associated with the progression of vascular complications in subjects with type 2 diabetes mellitus.<\/jats:p>","DOI":"10.1038\/s41598-022-21688-1","type":"journal-article","created":{"date-parts":[[2022,10,13]],"date-time":"2022-10-13T10:02:53Z","timestamp":1665655373000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Association between changes in pancreatic morphology and vascular complications in subjects with type 2 diabetes mellitus: a retrospective study"],"prefix":"10.1038","volume":"12","author":[{"given":"Yuichiro","family":"Iwamoto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomohiko","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuminori","family":"Tatsumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshitomo","family":"Sugisaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masato","family":"Kubo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erina","family":"Nakao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazunori","family":"Dan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryo","family":"Wamata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideyuki","family":"Iwamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaio","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junpei","family":"Sanada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiro","family":"Fushimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukino","family":"Katakura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masashi","family":"Shimoda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuhei","family":"Nakanishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoatsu","family":"Mune","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kohei","family":"Kaku","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideaki","family":"Kaneto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,10,13]]},"reference":[{"issue":"1","key":"21688_CR1","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1111\/j.1464-5491.1988.tb00938.x","volume":"5","author":"AS Rudenski","year":"1988","unstructured":"Rudenski, A. S. et al. Natural history of pancreatic islet B-cell function in type 2 diabetes mellitus studied over six years by homeostasis model assessment. Diabet. Med. 5(1), 36\u201341 (1988).","journal-title":"Diabet. Med."},{"issue":"8","key":"21688_CR2","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1111\/j.1464-5491.1993.tb00160.x","volume":"10","author":"A Alzaid","year":"1993","unstructured":"Alzaid, A., Aideyan, O. & Nawaz, S. The size of the pancreas in diabetes mellitus. Diabet. Med. 10(8), 759\u2013763 (1993).","journal-title":"Diabet. Med."},{"issue":"5","key":"21688_CR3","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1007\/s00592-014-0581-3","volume":"51","author":"S Lim","year":"2014","unstructured":"Lim, S. et al. Differences in pancreatic volume, fat content, and fat density measured by multidetector-row computed tomography according to the duration of diabetes. Acta Diabetol. 51(5), 739\u2013748 (2014).","journal-title":"Acta Diabetol."},{"issue":"1","key":"21688_CR4","doi-asserted-by":"publisher","first-page":"102","DOI":"10.2337\/diabetes.52.1.102","volume":"52","author":"AE Butler","year":"2003","unstructured":"Butler, A. E. et al. Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes. Diabetes 52(1), 102\u2013110 (2003).","journal-title":"Diabetes"},{"issue":"5","key":"21688_CR5","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0126825","volume":"10","author":"M Macauley","year":"2015","unstructured":"Macauley, M. et al. Altered volume, morphology and composition of the pancreas in type 2 diabetes. PLoS One 10(5), e0126825 (2015).","journal-title":"PLoS One"},{"key":"21688_CR6","doi-asserted-by":"publisher","first-page":"6371231","DOI":"10.1155\/2019\/6371231","volume":"2019","author":"J Lu","year":"2019","unstructured":"Lu, J. et al. Association between pancreatic atrophy and loss of insulin secretory capacity in patients with type 2 diabetes mellitus. J. Diabetes Res. 2019, 6371231 (2019).","journal-title":"J. Diabetes Res."},{"key":"21688_CR7","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1001\/archinte.1916.00080130010002","volume":"17","author":"D Du Bois","year":"1916","unstructured":"Du Bois, D. & Du Bois, E. F. A formula to estimate the approximate surface area if height and weight be known. Arch Intern. Med. 17, 863\u2013871 (1916).","journal-title":"Arch Intern. Med."},{"issue":"5","key":"21688_CR8","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0062561","volume":"8","author":"HY Ou","year":"2013","unstructured":"Ou, H. Y. et al. The association between nonalcoholic fatty pancreas disease and diabetes. PLoS ONE 8(5), e62561 (2013).","journal-title":"PLoS ONE"},{"issue":"11","key":"21688_CR9","doi-asserted-by":"publisher","first-page":"2916","DOI":"10.2337\/dc07-0326","volume":"30","author":"ME Tushuizen","year":"2007","unstructured":"Tushuizen, M. E. et al. Pancreatic fat content and beta-cell function in men with and without type 2 diabetes. Diabetes Care 30(11), 2916\u20132921 (2007).","journal-title":"Diabetes Care"},{"issue":"2","key":"21688_CR10","doi-asserted-by":"publisher","first-page":"476","DOI":"10.3892\/etm.2015.2925","volume":"11","author":"J Chai","year":"2016","unstructured":"Chai, J. et al. MRI chemical shift imaging of the fat content of the pancreas and liver of patients with type 2 diabetes mellitus. Exp. Ther. Med. 11(2), 476\u2013480 (2016).","journal-title":"Exp. Ther. Med."},{"issue":"7","key":"21688_CR11","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1007\/BF00280883","volume":"28","author":"DR Matthews","year":"1985","unstructured":"Matthews, D. R. et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28(7), 412\u2013419 (1985).","journal-title":"Diabetologia"},{"issue":"4","key":"21688_CR12","doi-asserted-by":"publisher","first-page":"318","DOI":"10.4093\/dmj.2016.40.4.318","volume":"40","author":"YS Song","year":"2016","unstructured":"Song, Y. S. et al. Comparison of the usefulness of the updated homeostasis model assessment (HOMA2) with the original HOMA1 in the prediction of type 2 diabetes mellitus in Koreans. Diabetes Metab. J. 40(4), 318\u2013325 (2016).","journal-title":"Diabetes Metab. J."},{"issue":"10","key":"21688_CR13","doi-asserted-by":"publisher","first-page":"3013","DOI":"10.1111\/cas.13766","volume":"109","author":"M Takahashi","year":"2018","unstructured":"Takahashi, M. et al. Fatty pancreas: A possible risk factor for pancreatic cancer in animals and humans. Cancer Sci. 109(10), 3013\u20133023 (2018).","journal-title":"Cancer Sci."},{"issue":"7","key":"21688_CR14","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/S0046-8177(84)80294-4","volume":"15","author":"BH Stamm","year":"1984","unstructured":"Stamm, B. H. Incidence and diagnostic significance of minor pathologic changes in the adult pancreas at autopsy: A systematic study of 112 autopsies in patients without known pancreatic disease. Hum. Pathol. 15(7), 677\u2013683 (1984).","journal-title":"Hum. Pathol."},{"issue":"2","key":"21688_CR15","doi-asserted-by":"publisher","first-page":"e2955","DOI":"10.1002\/dmrr.2955","volume":"34","author":"V Guglielmi","year":"2018","unstructured":"Guglielmi, V. & Sbraccia, P. Type 2 diabetes: Does pancreatic fat really matter?. Diabetes Metab Res Rev 34(2), e2955 (2018).","journal-title":"Diabetes Metab Res Rev"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-21688-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-21688-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-21688-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,13]],"date-time":"2022-10-13T10:18:32Z","timestamp":1665656312000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-21688-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,13]]},"references-count":15,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["21688"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-21688-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,13]]},"assertion":[{"value":"25 April 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"H.K. has received honoraria for lectures, received scholarship grants, and received research grant from Novo Nordisk Pharma, Sanofi, Eli Lilly, Boehringer Ingelheim, Taisho Pharma, Sumitomo Dainippon Pharma, Takeda Pharma, Ono Pharma, Daiichi Sankyo, Mitsubishi Tanabe Pharma, Kissei Pharma, MSD, AstraZeneca, Astellas, Novartis, Kowa, Abbott. K.K. has been an advisor to, received honoraria for lectures from, and received scholarship grants from Novo Nordisk Pharma, Sanwa Kagaku, Takeda, Taisho Pharma, MSD, Kowa, Sumitomo Dainippon Pharma, Novartis, Mitsubishi Tanabe Pharma, AstraZeneca, Boehringer Ingelheim, Chugai, Daiichi Sankyo, Sanofi.\n    Other authors (Yuichiro Iwamoto, Tomohiko Kimura, Fuminori Tatsumi, Toshitomo Sugisaki, Masato Kubo, Erina Nakao, Kazunori Dan, Ryo Wamata, Hideyuki Iwamoto, Kaio Takahashi, Junpei Sanada, Yoshiro Fushimi, Yukino Katakura, Masashi Shimoda, Shuhei Nakanishi, Tomoatsu Mune) do not have conflicts of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"17166"}}